Articles citing this paper
Treatment of metronidazole-resistant Trichomonas vaginalis
Linda M. Goldman A D , Jacqueline A. Upcroft B , Kimberly Workowski C and Andrea Rapkin A
+ Author Affiliations
- Author Affiliations
A The David Geffen School of Medicine, UCLA, 200 Medical Plaza Suite #430, Los Angeles, CA 90095, USA.
B Queensland Institute of Medical Research, The Bancroft Centre, 300 Herston Road, Brisbane, Qld 4006, Australia.
C Emory University Division of Infectious Diseases, 550 Peachtree Street, Suite 7000, Atlanta, GA 30308, USA.
D Corresponding author. Email: lgoldman@mednet.ucla.edu
Sexual Health 6(4) 345-347 https://doi.org/10.1071/SH09064
Submitted: 17 June 2009 Accepted: 10 July 2009 Published: 13 November 2009
25 articles found in Crossref database.
Resistant Trichomoniasis: Successful Treatment With Combination Therapy
Nyirjesy Paul,
Gilbert Jeffrey, Mulcahy Laura J.
Sexually Transmitted Diseases. 2011 38(10). p.962
Trichomonas vaginalis flavin reductase 1 and its role in metronidazole resistance
Leitsch David,
Janssen Brian D.,
Kolarich Daniel,
Johnson Patricia J., Duchêne Michael
Molecular Microbiology. 2014 91(1). p.198
Neglected Tropical Diseases - North America (2021)
Ultrastructural alterations induced by Δ24(25)-sterol methyltransferase inhibitors on Trichomonas vaginalis
de Andrade Rosa Ivone,
Rocha Débora Afonso Silva,
de Souza Wanderley,
Urbina Julio A., Benchimol Marlene
FEMS Microbiology Letters. 2011 315(1). p.72
Recent Advances in the Trichomonas vaginalis Field
Leitsch David
F1000Research. 2016 5 p.162
In Vitro
Study of the Susceptibility of Clinical Isolates of Trichomonas vaginalis to Metronidazole and Secnidazole
Ghosh Arindam P.,
Aycock Cheri, Schwebke Jane R.
Antimicrobial Agents and Chemotherapy. 2018 62(4).
Sexually Transmitted Infections in HIV-Infected Adults and Special Populations (2017)
Comprehensive characterization of purine and pyrimidine transport activities in Trichomonas vaginalis and functional cloning of a trichomonad nucleoside transporter
Natto Manal J.,
Miyamoto Yukiko,
Munday Jane C.,
AlSiari Tahani A.,
Al‐Salabi Mohammed I.,
Quashie Neils B.,
Eze Anthonius A.,
Eckmann Lars, De Koning Harry P.
Molecular Microbiology. 2021 116(6). p.1489
Getting trichy: tools and approaches to interrogating Trichomonas vaginalis in a post-genome world
Conrad Melissa D.,
Bradic Martina,
Warring Sally D.,
Gorman Andrew W., Carlton Jane M.
Trends in Parasitology. 2013 29(1). p.17
Nanoliposomes increases Anti-Trichomonas vaginalis and apoptotic activities of metronidazole
Ebrahimi Mina,
Montazeri Mahbobeh,
Ahmadi Amirhosien,
Nami Sanam,
Hamishehkar Hamed,
Shahrivar Firooz,
Bakhtiar Nayer Mehdizad,
Nissapatorn Veeranoot,
Spotin Adel, Ahmadpour Ehsan
Acta Tropica. 2021 224 p.106156
Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2′-deoxyadenosine
Wright Janelle M.,
Dunn Linda A.,
Kazimierczuk Zygmunt,
Burgess Anita G.,
Krauer Kenia G.,
Upcroft Peter, Upcroft Jacqueline A.
Parasitology Research. 2010 107(4). p.847
The clinical spectrum ofTrichomonas vaginalisinfection and challenges to management
Muzny Christina A, Schwebke Jane R
Sexually Transmitted Infections. 2013 89(6). p.423
Pentamycin shows high efficacy against Trichomonas vaginalis
Kranzler Markus,
Syrowatka Michael,
Leitsch David,
Winnips Cornelis, Walochnik Julia
International Journal of Antimicrobial Agents. 2015 45(4). p.434
Chemotherapeutic options for the treatment of human trichomoniasis
Küng Erik,
Fürnkranz Ursula, Walochnik Julia
International Journal of Antimicrobial Agents. 2019 53(2). p.116
Down-regulation of flavin reductase and alcohol dehydrogenase-1 (ADH1) in metronidazole-resistant isolates of Trichomonas vaginalis
Leitsch David,
Drinić Mirjana,
Kolarich Daniel, Duchêne Michael
Molecular and Biochemical Parasitology. 2012 183(2). p.177
Refractory Trichomoniasis in HIV-positive and HIV-negative Subjects
Miller Megan R., Nyirjesy Paul
Current Infectious Disease Reports. 2011 13(6).
Persistent and recurrentTrichomonas vaginalisinfections: epidemiology, treatment and management considerations
Seña Arlene C,
Bachmann Laura H, Hobbs Marcia M
Expert Review of Anti-infective Therapy. 2014 12(6). p.673
United Kingdom National Guideline on the Management of Trichomonas vaginalis 2014
Sherrard Jackie,
Ison Cathy,
Moody Judith,
Wainwright Emma,
Wilson Janet, Sullivan Ann
International Journal of STD & AIDS. 2014 25(8). p.541
Antimicrobial Drug Resistance (2017)
Gold(I) Phosphine Derivatives with Improved Selectivity as Topically Active Drug Leads to Overcome 5-Nitroheterocyclic Drug Resistance in Trichomonas vaginalis
Miyamoto Yukiko,
Aggarwal Shubhangi,
Celaje Jeff Joseph A.,
Ihara Sozaburo,
Ang Jonathan,
Eremin Dmitry B.,
Land Kirkwood M.,
Wrischnik Lisa A.,
Zhang Liangfang,
Fokin Valery V., Eckmann Lars
Journal of Medicinal Chemistry. 2021 64(10). p.6608
Symptomatic Trichomonas vaginalis infection in the setting of severe nitroimidazole allergy: successful treatment with boric acid
Muzny Christina,
Barnes Arti, Mena Leandro
Sexual Health. 2012 9(4). p.389
What Would We Do Without Metronidazole?
Stover Kayla R.,
Riche Daniel M.,
Gandy Christie L., Henderson Harold
The American Journal of the Medical Sciences. 2012 343(4). p.316
Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines
Kissinger Patricia J,
Gaydos Charlotte A,
Seña Arlene C,
Scott McClelland R,
Soper David,
Secor W Evan,
Legendre Davey,
Workowski Kimberly A, Muzny Christina A
Clinical Infectious Diseases. 2022 74(Supplement_2). p.S152
Trichomonas vaginalis Contact-Dependent Cytolysis of Epithelial Cells
Lustig Gila,
Ryan Christopher M.,
Secor W. Evan,
Johnson Patricia J., Urban J. F.
Infection and Immunity. 2013 81(5). p.1411
Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues
Kissinger Patricia
BMC Infectious Diseases. 2015 15(1).
